2003
DOI: 10.1152/ajpheart.00362.2003
|View full text |Cite
|
Sign up to set email alerts
|

Disruption of cardiac Ena-VASP protein localization in intercalated disks causes dilated cardiomyopathy

Abstract: .-Vasodilator-stimulated phosphoprotein (VASP) and mammalian enabled (Mena) are actin cytoskeleton and signaling modulators. Ena-VASP proteins share an identical domain organization with an NH2-terminal Ena VASP homology (EVH1) domain, which mediates the binding of these proteins to FPPPP-motif containing partners such as zyxin and vinculin. VASP and Mena are abundantly expressed in the heart. However, previous studies showed that disruption by gene targeting of VASP or Mena genes in mice did not reveal any ca… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
39
0

Year Published

2005
2005
2018
2018

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 42 publications
(40 citation statements)
references
References 34 publications
1
39
0
Order By: Relevance
“…3C). The cardiac changes probably initiated the embryonic lethality, and were reminiscent of cardiac phenotypes observed following the disruption of TGF-b-Smad signaling (Qi et al, 2007) or following the loss of proteins that regulate actin dynamics such as Ena/VASP (Eigenthaler et al, 2003). Interestingly, both TGF-b-Smad signaling (Tang et al, 2003) and Ena/VASP (Bournier et al, 2006) interact with spectrin, although the levels of neither Ena/VASP (supplementary material Fig.…”
Section: Resultsmentioning
confidence: 97%
“…3C). The cardiac changes probably initiated the embryonic lethality, and were reminiscent of cardiac phenotypes observed following the disruption of TGF-b-Smad signaling (Qi et al, 2007) or following the loss of proteins that regulate actin dynamics such as Ena/VASP (Eigenthaler et al, 2003). Interestingly, both TGF-b-Smad signaling (Tang et al, 2003) and Ena/VASP (Bournier et al, 2006) interact with spectrin, although the levels of neither Ena/VASP (supplementary material Fig.…”
Section: Resultsmentioning
confidence: 97%
“…Development 133 (4) in somitogenesis were observed in embryos expressing an EVH1-GFP dominant-negative protein (Eigenthaler et al, 2003;Vasioukhin et al, 2000), providing additional evidence that the phenotype is specific to inhibition of Ena/VASP function (data not shown). FP 4 -mito expression also resulted in disruption of myotomal junctions, as assessed by immunostaining of tenascin, ␤1-integrin and vinculin (data not shown).…”
Section: Research Articlementioning
confidence: 89%
“…To overcome the problem of redundancy, several studies have used dominant-negative proteins to neutralize the function of all Ena/VASP proteins. This work has revealed additional roles for Ena/VASP proteins in formation of cell-cell junctions in epithelial cells (Vasioukhin et al, 2000), regulation of intercalated disc function in cardiac muscle (Eigenthaler et al, 2003) and migration of pyramidal neurons in the cerebral cortex (Goh et al, 2002). Furthermore, dominant-negative proteins have also been employed to examine the mechanism by which Ena/VASP proteins regulate actin dynamics and cell motility in cultured fibroblasts Bear et al, 2002).…”
Section: Introductionmentioning
confidence: 99%
“…Recently, the EVH-1 structure of Spred proteins has also been enlightened (54). The EVH-1 domain of VASP was shown to act as a dominant negative form when overexpressed in cardiac myocytes (55). Overexpression of a ⌬C-mutant of Spred-1, missing the Sprouty domain but still containing the EVH-1 and the c-Kit binding domains, demonstrated the dominant negative behavior of Spred-EVH1, as well (45).…”
Section: Dwarfism In Spred-2mentioning
confidence: 99%